How to get your drug to market faster

The pressure to take your drug to market faster is increasing. To achieve a successful journey to the first clinical trial phase in the fastest time possible, Eppendorf has identified three key elements that it is addressing in an eBook.

  •  Comply with audit requirements and relevant certifications
  •  Drive process efficiencies with increased speed whilst not sacrificing quality
  •  Be reliable to avoid unplanned downtime

These elements are all relevant to the biologics discovery to manufacture monoclonal antibodies, recombinant vaccines and mRNA vaccines and therapeutics.

Eppendorf says that the common step in all three workflows is cloning. Creating an optimised antigen in your upstream development and driving efficiencies is the basis for a successful downstream drug discovery process.

The eBook outlines the benefit of:

  • Digitalising your workflow from the start
  • Employing faster, more reliable and intuitive equipment
  • Planned maintenance service contracts

Download the interactive eBook to find out how Eppendorf products and solutions can get you to the clinical phase faster.

*To experience this eBook with all features, please use Adobe to view

Image credit: Volodymyr Hryshchenko

 

 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free